Metabolic alterations and vulnerabilities in hepatocellular carcinoma
Daniel G Tenen, Li Chai, Justin L Tan
Gastroenterology Report, Volume 9, Issue 1, January 2021, Pages 1–13, https://doi.org/10.1093/gastro/goaa066
Published:
18 November 2020
Article history
Liver cancer is a serious disease. It is ranked as the cancer with the second highest number of cancer-related deaths worldwide. Hepatocellular carcinoma (HCC), which arises from transformed hepatocytes, is the major subtype of liver cancer. It accounts for 85% of total liver-cancer cases. An important aspect of HCC that has been actively studied is its metabolism. With the liver as the primary site of numerous metabolic processes in the body, it has been shown that the metabolism of HCC cells is highly dysregulated compared to that of normal hepatocytes. It is therefore crucial to understand the metabolic alterations caused by HCC and the underlying mechanisms for these alterations. This deeper understanding will allow diagnostic and therapeutic advancements in the treatment of HCC. In this review, we will summarize the current literature in HCC metabolic alterations, induced vulnerabilities, and potential therapeutic interventions.
hepatocellular carcinoma (HCC), metabolism, metabolic vulnerability, targeted therapy
Topic:
metabolism cancer fat metabolism carcinoma, hepatocellular hepatocytes oxidative phosphorylation diagnosis enzymes liver liver cancer cancer death rate metabolic disturbance emotional vulnerability
作者: StephenW 时间: 2021-3-20 05:48
肝细胞癌的代谢改变和脆弱性
Daniel G Tenen，李柴，Justin L Tan
胃肠病学报告，第21卷，第21卷，2021年1月，第1-13页，https：//doi.org/10.1093/gastro/goaa066
发布时间：
2020年11月18日
文章历史